510(k) Report

510(k) · Cleared

Cleared

Methadone Enzyme Immunoassay

K023317510(k) TraditionalCleared Dec 12, 200270-day reviewClass II21 CFR 862.3620

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lin-Zhi International, Inc. · DJR Enzyme Immunoassay, Methadone

Cleared on Dec 12, 2002 as substantially equivalent to K972526 (Diagnostic Reagents, Inc., 1997) after a 70-day review. Its family tree reaches back 1 generation to 1997. 2 later devices descend from it.

Decided
Dec 12, 2002
Review
70 days
Class
Class II
Product code
DJR
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K972526 (1997). 2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2004: 1 descendant cleared2019: 1 descendant clearedK972526 · Methadone Eia Assay · Diagnostic Reagents, Inc. · 19971995200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants K972526 · Methadone Eia Assay · Diagnostic Reagents, Inc. · 19970
  1. Root · 1 generation backK972526 Methadone Eia AssayDiagnostic Reagents, Inc. · 1997
  2. This deviceK023317 Methadone Enzyme ImmunoassayLin-Zhi International, Inc. · 2002
  3. Descendant · cites it directly · 0 of its ownK192433 LZI Methadone II Enzyme ImmunoassayLin-Zhi International, Inc. · 2019
  4. Descendant · cites it directly · 0 of its ownK033885 BMBP Enzyme Immunoassay, Cat #0610, 0611 (500, 5000 Test Kit)Lin-Zhi International, Inc. · 2004

Most influential descendants

Showing 2 of 2 · See all
  • K192433LZI Methadone II Enzyme ImmunoassayLin-Zhi International, Inc. · 2019 · cites it directly0descendants
  • K033885BMBP Enzyme Immunoassay, Cat #0610, 0611 (500, 5000 Test Kit)Lin-Zhi International, Inc. · 2004 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K972526Methadone Eia AssayDiagnostic Reagents, Inc.1997—
0 (this device)K023317Methadone Enzyme ImmunoassayLin-Zhi International, Inc.2002—
+1K192433LZI Methadone II Enzyme ImmunoassayLin-Zhi International, Inc.2019—
+1K033885BMBP Enzyme Immunoassay, Cat #0610, 0611 (500, 5000 Test Kit)Lin-Zhi International, Inc.2004—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
201910
FIG. 1 — Lineage of K023317, 1997–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DJR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972526Methadone Eia Assay
Summary page 1
…nal, Inc. ’ Methadone Enzyme Immunoassay is substantially equivalent to the Methadone Enzyme Immunoassay (By DRIhficrogenics Corp.), cleared under premarket notification K972526. LZI’s Methadone Enzyme Immunoassay is identical or similar to its predicate in terms of intended use, method principle, device…
Diagnostic Reagents, Inc.1997—

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K192433LZI Methadone II Enzyme ImmunoassayLin-Zhi International, Inc.20190
K033885BMBP Enzyme Immunoassay, Cat #0610, 0611 (500, 5000 Test Kit)Lin-Zhi International, Inc.20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K192433 (Lin-Zhi International, Inc., 2019) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DJR devices

DJR Enzyme Immunoassay, Methadone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DJR

1in 2019

2009: 12010: 32013: 12015: 32016: 12017: 12018: 12019: 1
2007high 3 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DJR

59in 2015

2010: 469 days median2015: 59 days median
2007high 469 (2010) · low 59 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DJR

1in 2010

2008: 22009: 12010: 1
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DJR

1in 2025

2010: 32011: 62012: 12014: 22015: 22016: 12025: 1
2007high 6 (2011) · low 0 (2007)2025

MAUDE reports naming product code DJR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—20
20091—10
2010346913
20110—06
20120—01
20131—00
20140—02
201535902
20161—01
20171—00
20181—00
20191—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—01
20260—0—

What is it indicated for?

The Methadone Enzyme Immunoassay is a homogeneous enzyme immunoassay with a 300 ng/mL cutoff. The assay is intended for use in the qualitative and semi-quantitative analyses of methadone in human urine. The assay is designed for professional use with a number of automated clinical chemistry analyzers. The Methadone Enzyme Immunoassay provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a…

Read the full statement (101 words)

The Methadone Enzyme Immunoassay is a homogeneous enzyme immunoassay with a 300 ng/mL cutoff. The assay is intended for use in the qualitative and semi-quantitative analyses of methadone in human urine. The assay is designed for professional use with a number of automated clinical chemistry analyzers.

The Methadone Enzyme Immunoassay provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirmed analytical result. Gas chromatogaphy/mass spectrometry (GUMS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug-of-abuse test result, particularly when preliminary positive results are used.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K023317: Methadone Enzyme Immunoassay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K023317

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026